Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05326464
Title Tofacitinib in Recurrent GBM Patients
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors University of Texas Southwestern Medical Center
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST